A recent Brazilian study suggests that fish oil may play a key role in reducing insulin resistance and improving glucose tolerance, offering hope for non-obese individuals with type 2 diabetes.
A groundbreaking Brazilian study has revealed that fish oil supplementation could potentially reverse insulin resistance, particularly in non-obese individuals. The study, published in Nutrients, sheds new light on the relationship between omega-3 fatty acids and insulin resistance, offering hope for the 10%–20% of the global population with non-obese type 2 diabetes.
This preclinical research, funded by FAPESP, was conducted on Goto-Kakizaki (GK) rats, a model for non-obese type 2 diabetes. For eight weeks, rats were administered 2 grams of fish oil per kilogram of body weight, containing 540 mg/g of eicosapentaenoic acid (EPA) and 100 mg/g of docosahexaenoic acid (DHA). The results showed a remarkable reduction in insulin resistance, accompanied by improved blood sugar levels, lipid profiles, and inflammatory markers.
Omega-3 fatty acids have long been recognized for their cardiovascular benefits, but their impact on insulin resistance in non-obese individuals was poorly understood. This study is the first to demonstrate that fish oil supplementation can modulate immune cells—particularly lymphocytes—by shifting them from a pro-inflammatory to an anti-inflammatory state, thereby reversing insulin resistance.
Rui Curi, director of the Butantan Institute and coordinator of the study, explained that the findings suggest a potential link between inflammation and insulin resistance, even in the absence of obesity. The altered immune response seen in the GK rats parallels what is observed in obese individuals with insulin resistance, where immune cells like lymphocytes and macrophages produce pro-inflammatory cytokines.
The study further highlights the critical role of systemic inflammation in the development of insulin resistance. While obesity is a well-known risk factor, systemic inflammation in non-obese individuals may also contribute to the onset of type 2 diabetes. Curi suggests that the primary cause of insulin resistance in non-obese individuals could be genetic, and further research is necessary to explore the full range of factors contributing to the condition.
The study’s findings open new possibilities for treating non-obese type 2 diabetes patients, offering a potential therapeutic route that avoids the need for weight loss. This exciting research paves the way for further investigations into the impact of omega-3 fatty acids on diabetes and related metabolic conditions.
The researchers plan to continue studying the mechanisms behind insulin resistance in non-obese animals, expanding their understanding of how systemic inflammation influences diabetes. If future studies confirm the potential of fish oil in managing insulin resistance, it could revolutionize the way we treat diabetes and other inflammatory diseases.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from...
Melting glaciers, recurring droughts and dust storms are putting growing pressure on Central Asia’s water resources, agriculture and public h...
Iran’s Assembly of Experts has backed withdrawing from the Nuclear Non-Proliferation Treaty (NPT) and overhauling the country’s defence...
European leaders gathered in Dublin on Thursday, 12 November, for the ninth European Political Community (EPC) summit, with security, defence and energy high on the agenda. Azerbaijani President Ilham Aliyev held talks focused on peace, trade and regional cooperation.
Iran will not let a single particle of its enriched nuclear material leave the country, and any new U.S. attack would be met with strikes on distant American bases, Iranian security chief Mohsen Rezaei has said.
Nvidia chief executive Jensen Huang is stepping down amid reports linking him to a woman suspected by U.S. authorities of spying for China, throwing the future of the $4 trillion chipmaker into uncertainty.
Four million workers across Spain joined a general strike on Wednesday over the country’s deepening housing crisis, unions said, bringing disruption to factories, ports, shops and public transport just weeks before a snap general election.
Kazakhstan’s security service has arrested Nurlan Zhakupov, CEO of Samruk-Kazyna, the country’s sovereign wealth fund, on suspicion of corruption. Yelzhas Otynshiyev, Chairman of KTZ, Kazakhstan’s national railway firm has also been detained.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from the body, a process that may break down early in Alzheimer’s disease and offer a new target for treatment.
Here's your AnewZ Daily Brief for the 5th of November, as health emergencies, humanitarian crises, political shifts, and cybersecurity threats put governments and essential services under pressure across the globe. Here are five stories worth your attention.
Kazakhstan plans to manufacture 494 types of medicines through eight major investment projects worth a combined $862 million, Health Minister Akmaral Alnazarova announced on 3 November, local media reported.
Dengue fever has killed more people in Bangladesh this year than in the whole of 2025, with October the deadliest month so far, data from Bangladesh's Health Ministry shows.
Visitors to Armenia could face temperature screening after a lab worker died from suspected Pneumonic plague in Russia, Yerevan’s Health Minister Anahit Avanesyan told lawmakers on Wednesday, Armenian state news agency Armenpress reported.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment